Anemia

Hematology·MeSH: Anemia

65 drugs in development·42 companies·15 clinical trials

Drug Pipeline by Phase

Approved(17)

Drug	Company
auryxia	KERYX BIOPHARMACEUTICALS INC (KERYX)
azacitidine	Amneal Pharmaceuticals, Inc. (AMRX)
Dr. Xiao Brand Huangjingdanggui Tablet	China Health Industries Holdings, Inc. (CHHE)
Dr. Xiao Huangjingdanggui Tablet	China Health Industries Holdings, Inc. (CHHE)
EVRENZO (爱瑞卓®) / roxadustat	KYNTRA BIO INC. (KYNB)
felbamate	ANI PHARMACEUTICALS INC (ANIP)
lenalidomide	Mylan II B.V. (MYL)
leucovorin calcium preservative free	Seagen Inc. (SGEN)
leucovorin calcium preservative free	Mylan II B.V. (MYL)
promacta	Novartis AG (NVS)
Promacta	Royalty Pharma plc (RPRX)
PYRUKYND®	AGIOS PHARMACEUTICALS, INC. (AGIO)
rytelo	GERON CORP (GERN)
Rytelo	Royalty Pharma plc (RPRX)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
Vafseo	Akebia Therapeutics, Inc. (AKBA)
vykoura	Kaya Holdings, Inc. (KAYS)

Phase 3(24)

Drug	Company
Auryxia	Akebia Therapeutics, Inc. (AKBA)
bitopertin	Disc Medicine, Inc. (IRON)
cyclosporine	Structure Therapeutics Inc. (GPCR)
cyclosporine	Filana Therapeutics Inc. (FLNA)
cyclosporine	Crinetics Pharmaceuticals, Inc. (CRNX)
cyclosporine	ENANTA PHARMACEUTICALS INC (ENTA)
Elritercept	ENANTA PHARMACEUTICALS INC (ENTA)
Elritercept	Crinetics Pharmaceuticals, Inc. (CRNX)
elritercept (KER-050)	Keros Therapeutics, Inc. (KROS)
Epoetin Alfa	Crinetics Pharmaceuticals, Inc. (CRNX)
erythropoiesis stimulating agent	GH Research PLC (GHRS)
Erythropoiesis-Stimulating Agent	Akebia Therapeutics, Inc. (AKBA)
ferric	KERYX BIOPHARMACEUTICALS INC (KERYX)
ferumoxytol	AMAG PHARMACEUTICALS, INC. (AMAG)
Fludarabine	Crinetics Pharmaceuticals, Inc. (CRNX)
hmpl-523	HUTCHMED (China) Limited (HCM)
horse anti-thymocyte globulin	Crinetics Pharmaceuticals, Inc. (CRNX)
Luspatercept	BRISTOL MYERS SQUIBB CO (BMY)
Obexelimab	Xencor Inc (XNCR)
parsaclisinib	Incyte Corp. (INCY)
rabbit anti-thymocyte globulin	Crinetics Pharmaceuticals, Inc. (CRNX)
Reblozyl	Merck & Co., Inc. (MRK)
roxadustat	KYNTRA BIO INC. (KYNB)
Vadadustat	Akebia Therapeutics, Inc. (AKBA)

Phase 2(9)

Drug	Company
AG-946	AGIOS PHARMACEUTICALS, INC. (AGIO)
Elritercept	Merus N.V. (MRUS)
erepoxen	Xenetic Biosciences, Inc. (XBIO)
Haploidentical donor bone marrow transplant	Sanofi (SNY)
incb000928	Incyte Corp. (INCY)
obexelimab	Zenas BioPharma, Inc. (ZBIO)
rabbit ATG, Cyclosporine, Levamisole	ENANTA PHARMACEUTICALS INC (ENTA)
rp-l102	Rocket Pharmaceuticals Inc. (RCKT)
Unrelated donor bone marrow transplant	Sanofi (SNY)

Phase 1(8)

Drug	Company
2D UC-MSC group	Accustem Sciences Inc. (ACUT)
3D hypoxia-preconditioned UC-MSC group	Accustem Sciences Inc. (ACUT)
apg-5918	CHINA PHARMA HOLDINGS, INC. (CPHI)
apg-5918	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
CTX112	CRISPR Therapeutics AG (CRSP)
disc-0974	Disc Medicine, Inc. (IRON)
hemaxellerate	Regen BioPharma Inc (RGBPP)
rlyb331	Rallybio Corp (RLYB)

Preclinical(4)

Drug	Company
ergod2 hemo	ENTIA BIOSCIENCES, INC. (ERGO)
hemaxellarate	Regen BioPharma Inc (RGBPP)
Orally available EPOR agonists	Viking Therapeutics, Inc. (VKTX)
SRK-256	Scholar Rock Holding Corp (SRRK)

Phase 1/Phase 2(1)

Drug	Company
zugo-cel	CRISPR Therapeutics AG (CRSP)

Phase 4(2)

Drug	Company
bms-986470	BRISTOL MYERS SQUIBB CO (BMY)
Epoetin Alfa	UNITED THERAPEUTICS Corp (UTHR)

BioSniper tracks 65 drugs in development for Anemia across 42 companies.

There are 15 clinical trials targeting Anemia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.